Search for: "WYETH-AYERST LABORATORIES"
Results 21 - 40
of 61
Sorted by Relevance
|
Sort by Date
18 Jun 2012, 6:51 am
Wyeth-Ayerst Laboratories, 283 F.3d 315 (5th Cir. 2002), and Williams v. [read post]
1 Jul 2010, 5:00 am
Wyeth-Ayerst Laboratories, 992 S.W.2d 797 (Ark. [read post]
24 Feb 2011, 1:49 pm
Wyeth-Ayerst Laboratories, 1999 WL 33548540, at *1 (S.D. [read post]
31 Mar 2007, 9:11 am
Wyeth-Ayerst Laboratories, 385 F.3d 961 (6th Cir. 2004). [read post]
2 Jun 2011, 12:46 pm
Ayerst Laboratories, 548 A.2d 798, 801 & n.6 (D.C. 1988). [read post]
6 Mar 2013, 10:08 am
Wyeth-Ayerst Laboratories, 283 F.3d 315 (5th Cir. 2002), involved a product that delivered the medical benefits consumers expected, and there was no allegation that they paid more than they would have if the alleged risks had been properly disclosed. [read post]
3 Jul 2008, 7:26 pm
Wyeth-Ayerst Laboratories, Division of Amer [read post]
19 Jul 2007, 1:47 pm
Wyeth Laboratories, Inc., 1986 WL 720792, at *10 (S.D.W. [read post]
11 Sep 2012, 11:36 am
Wyeth-Ayerst Laboratories, 385 F.3d 961 (6th Cir. 2004), that the fraud exception to Michigan’s bar on products liability suits against drug manufacturers is preempted, even where Plaintiffs haven’t alleged fraud-on-the-FDA in the classical sense.Plaintiffs brought consolidated products-liability actions against drug manufacturers Genentech, Inc. and Xoma (U.S.) [read post]
17 Mar 2010, 7:27 am
Wyeth-Ayerst Laboratories, 385 F.3d 961 (6th Cir. 2004). [read post]
6 Sep 2010, 10:21 am
Wyeth-Ayerst Laboratories, 385 F.3d 961 (6th Cir. 2004), and the anti-preemption position set forth by the Second Circuit in Desiano v. [read post]
6 Jul 2007, 4:29 am
Ayerst Laboratories, 548 A.2d 798, 802 n.6 (D.C. 1988). [read post]
2 Sep 2009, 11:22 pm
Wyeth-Ayerst Laboratories, 385 F.3d 961 (6th Cir. 2004), and Desiano v. [read post]
20 Jan 2011, 12:50 pm
July 3, 2003); Wyeth-Ayerst Laboratories Co. v. [read post]
15 Jul 2010, 2:39 pm
Wyeth, Inc., 613 F. [read post]
14 Mar 2008, 6:07 am
Wyeth-Ayerst Laboratories Co., the court encountered the redoubtable (we would say, very doubtable) Dr. [read post]
12 Mar 2024, 12:46 pm
Wyeth-Ayerst Laboratories Co., 278 F.Supp.2d 684, 700 (W.D.N.C. 2003) (expert witnesses may not opine about corporate intent and motive) (barring Dr. [read post]
23 Sep 2010, 11:56 am
Wyeth-Ayerst Laboratories, 385 F.3d 961 (6th Cir. 2004)]. . . . [read post]
27 May 2010, 3:40 pm
Wyeth-Ayerst Laboratories, 1996 WL 784566 (N.D. [read post]
3 Mar 2012, 5:36 pm
Wyeth-Ayerst Laboratories Co., appears to recognize that risk and cause are distinct concepts. 278 F. [read post]
